Fetal benefits of treating opioid use disorder during pregnancy are confirmed
Researchers used emergent MRI technology to understand the impact of prenatal opioid exposure on early brain development and the neural mechanism behind current medications.
In 1999 the prevalence of opioid use disorder in pregnant women in the USA was 1.5 per 1000 delivery hospitalizations, which are hospital stays due to maternal care rather than infant complications. By 2014 that number was 6.5 per 1000 – a quadrupling in the rate.